Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Bschor

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Psychiatry|November 2, 2020
Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-AnalysisLasse Brandt, Tom Bschor, Jonathan Henssler, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 9, 2003
Lithium augmentation therapy in refractory depression-update 2002Michael Bauer, Anna Forsthoff, Christopher Baethge, et al.
Journal of Clinical Psychopharmacology|August 13, 2002
How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depressionTom Bschor, Anne Berghöfer, Andreas Ströhle, et al.
Journal of Affective Disorders|March 17, 2004
Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-upChristopher Baethge, Philipp Gruschka, Anne Berghöfer, et al.
Journal of Psychiatry & Neuroscience : JPN|October 1, 2003
Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorderChristopher Baethge, Philipp Gruschka, Michael N Smolka, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 25, 2007
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary CareMichael Bauer, Tom Bschor, Andrea Pfennig, et al.
The Journal of Nervous and Mental Disease|February 23, 2017
Suicidal Ideation vs. Suicide Attempts: Clinical and Psychosocial Profile Differences Among Depressed Patients: A Study on Personality Traits, Psychopathological Variables, and Sociodemographic Factors in 228 PatientsUte Lewitzka, Sina Spirling, Dirk Ritter, et al.
Neuropsychobiology|May 11, 2010
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressantsMichael Bauer, Mazda Adli, Tom Bschor, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depressionTom Bschor, Manfred Uhr, Christopher Baethge, et al.
Depression and Anxiety|February 11, 2003
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depressionTom Bschor, Christopher Baethge, Mazda Adli, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Psychiatry|November 2, 2020
Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-AnalysisLasse Brandt, Tom Bschor, Jonathan Henssler, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 9, 2003
Lithium augmentation therapy in refractory depression-update 2002Michael Bauer, Anna Forsthoff, Christopher Baethge, et al.
Journal of Clinical Psychopharmacology|August 13, 2002
How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depressionTom Bschor, Anne Berghöfer, Andreas Ströhle, et al.
Journal of Affective Disorders|March 17, 2004
Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-upChristopher Baethge, Philipp Gruschka, Anne Berghöfer, et al.
Journal of Psychiatry & Neuroscience : JPN|October 1, 2003
Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorderChristopher Baethge, Philipp Gruschka, Michael N Smolka, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 25, 2007
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary CareMichael Bauer, Tom Bschor, Andrea Pfennig, et al.
The Journal of Nervous and Mental Disease|February 23, 2017
Suicidal Ideation vs. Suicide Attempts: Clinical and Psychosocial Profile Differences Among Depressed Patients: A Study on Personality Traits, Psychopathological Variables, and Sociodemographic Factors in 228 PatientsUte Lewitzka, Sina Spirling, Dirk Ritter, et al.
Neuropsychobiology|May 11, 2010
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressantsMichael Bauer, Mazda Adli, Tom Bschor, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depressionTom Bschor, Manfred Uhr, Christopher Baethge, et al.
Depression and Anxiety|February 11, 2003
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depressionTom Bschor, Christopher Baethge, Mazda Adli, et al.
Pageof 11